Carbidopa and Levodopa Sustained-release Tablets

Carbidopa and Levodopa Sustained-release Tablets
Product Description

For the treatment of Parkinson's disease and Parkinson's syndrome

Hunan Pagran Pharmaceutical Co., Ltd.

  • Country/Region:
    China
  • Founded:
    2022
  • On CPHI since:
    2026
  • Employees:
    100 - 249
Company types
CMO/CDMO
Specifications
  • Details
    Strength:Carbidopa 50 mg / Levodopa 200 mg;Carbidopa 25 mg / Levodopa 100 mg(as carbidopa and levodopa)Indications:For the treatment of Parkinson's disease and Parkinson's syndrome
  • Supplied from
    China

Hunan Pagran Pharmaceutical Co., Ltd.

  • Country/Region:
    China
  • Founded:
    2022
  • On CPHI since:
    2026
  • Employees:
    100 - 249
Company types
CMO/CDMO

More Products from Hunan Pagran Pharmaceutical Co., Ltd. (5)

  • Diclofenac Diethylamine Emulgel

    Product Diclofenac Diethylamine Emulgel

    Indications:For the relief of mild to moderate pain in muscles, soft tissues, and joints; also indicated for the symptomatic treatment of osteoarthritis
  • Diclofenac Epolamine Cataplasms

    Product Diclofenac Epolamine Cataplasms

    Indications:For the topical treatment of acute pain due to minor strains, sprains, and contusions in adult patients and pediatric patients aged 6 years and older
  • Ketoprofen Gel

    Product Ketoprofen Gel

    Indications:For the relief of pain associated with acute and chronic soft tissue sprains, strains, and contusions of the musculoskeletal system, as well as muscle overuse injuries; also indicated for the symptomatic treatment of osteoarthritis
  • Lidocaine Cataplasms

    Product Lidocaine Cataplasms

    Indications:For the relief of postherpetic neuralgia
  • Sildenafil Citrate Oral Soluble Film

    Product Sildenafil Citrate Oral Soluble Film

    Indications:For the treatment of erectile dysfunction